FY2019 EPS Estimates for icad inc. Cut by Zacks Investment Research (ICAD)

Receive News & Ratings for icad inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for icad inc. and related companies with MarketBeat.com's FREE daily email newsletter.

icad inc. (NASDAQ:ICAD) – Equities research analysts at Zacks Investment Research lowered their FY2019 EPS estimates for shares of icad inc. in a report issued on Wednesday. Zacks Investment Research analyst B. Marckx now expects that the technology company will post earnings per share of $0.03 for the year, down from their prior forecast of $0.05.

icad inc. (NASDAQ:ICAD) last issued its quarterly earnings results on Tuesday, August 8th. The technology company reported ($0.16) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.19) by $0.03. icad inc. had a negative return on equity of 44.39% and a negative net margin of 34.74%. The company had revenue of $6.41 million during the quarter, compared to analysts’ expectations of $6.41 million.

WARNING: This news story was first posted by [[site]] and is the property of of [[site]]. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at [[permalink]].

Separately, Laidlaw reissued a “buy” rating and set a $11.00 price target on shares of icad inc. in a report on Tuesday, July 25th.

Shares of icad inc. (ICAD) opened at 3.65 on Friday. The firm’s market cap is $60.57 million. icad inc. has a 12 month low of $2.82 and a 12 month high of $6.49. The firm’s 50-day moving average price is $3.92 and its 200-day moving average price is $4.35.

A number of large investors have recently made changes to their positions in ICAD. Essex Investment Management Co. LLC increased its stake in shares of icad inc. by 822.3% in the second quarter. Essex Investment Management Co. LLC now owns 139,766 shares of the technology company’s stock worth $586,000 after buying an additional 124,612 shares during the last quarter. Argent Capital Management LLC increased its stake in shares of icad inc. by 13.2% in the second quarter. Argent Capital Management LLC now owns 713,650 shares of the technology company’s stock worth $2,990,000 after buying an additional 82,967 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of icad inc. by 0.4% in the second quarter. Vanguard Group Inc. now owns 456,377 shares of the technology company’s stock worth $1,912,000 after buying an additional 2,007 shares during the last quarter. Hedge funds and other institutional investors own 25.16% of the company’s stock.

About icad inc.

iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).